In any event, our results show that LPS-enhanced metastasis to small bowel was remarkably reduced by treatment of BLT2 inhibitor LY255283 (Fig. 6A), suggesting that BLT2 might be associated with the LPS-induced breast cancer metastasis. Here, LTB4R2 is linked to breast cancer.